Results 21 to 30 of about 9,902,006 (336)
Journal of Endocrinological Investigation, 2020 To the Editor Since the outbreak of the SARS-CoV-2 pandemic, there have been many reports of autoimmune diseases triggered by or related to COVID-19 such as Guillain–Barre’s syndrome, autoimmune haemolytic anaemia, autoimmune thrombotic thrombocytopenic ...
M. Mateu-Salat, E. Urgell, A. Chico
semanticscholar +1 more source
European Journal of Case Reports in Internal Medicine, 2021 Graves' disease is the most frequent cause of hyperthyroidism in young women. This auto-immune disease is due to the production of class 1 IgG stimulating the TSH receptor.
Guillaume Pierman +2 more
semanticscholar +1 more source
Archives of Endocrinology and Metabolism, 2020 Objective Graves’ disease (GD) is the main cause of hyperthyroidism among adults. It is an autoimmune condition classically marked by the Merserburg Triad (goiter, thyrotoxicosis, and orbitopathy), but the change in presentation of GD over time has ...
Wanesa Pinto +4 more
doaj +1 more source
Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review [PDF]
Endocrinology and Metabolism, 2022 Background Immunoglobulin G4 (IgG4)-related disease is an entity that can involve the thyroid gland. The spectrum of IgG4-related thyroid disease (IgG4-RTD) includes Hashimoto thyroiditis (HT) and its fibrotic variant, Riedel thyroiditis, as well as ...
Meihua Jin +7 more
doaj +1 more source
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease [PDF]
Endocrinology and Metabolism, 2022 Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate.
Min Joo Kim +6 more
doaj +1 more source
Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review
Clinical Endocrinology, 2020 Thyroid eye disease (TED) is a debilitating condition that frequently manifests in patients suffering from Graves’ disease (GD). This study aims to analyse the prevalence of TED among GD patients, with a focus on geographical region‐specific rates.
Y. Chin +7 more
semanticscholar +1 more source
Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients [PDF]
Endocrinology and Metabolism, 2021 Background Programmed cell death-ligand 1 (PD-L1) has an important role in regulating immune reactions by binding to programmed death 1 (PD-1) on immune cells, which could prevent the exacerbation of autoimmune thyroid disease (AITD).
Jee Hee Yoon +7 more
doaj +1 more source
Microchimerism in Graves’ Disease [PDF]
, 2012 Microchimerism is the presence of cells from one individual in another genetically distinct individual. Pregnancy is the main cause of natural microchimerism through transplacental bidirectional cell trafficking between mother and ...
Galofre, J.C. (Juan Carlos)
core +3 more sources
Switching of Hashimoto Thyroiditis Into Graves’ Disease: A Case Report and Literature Review [PDF]
Disease and Diagnosis, 2021 Background: Hashimoto thyroiditis (HT) and Graves’ disease (GD) are autoimmune inflammatory thyroid disorders. The evolution from GD into HT is the most common scenario while the conversion from HT into GD seems to be less common. Case Presentation: A 20-
Rajab Maksoud +3 more
doaj +1 more source
In Graves' disease, increased muscle tension and reduced elasticity of affected muscles is primarily caused by active muscle contraction [PDF]
, 1989 In three patients with Graves' disease of recent onset, length-tension diagrams were made during surgery for squint under eyedrop anesthesia, while the other eye looked ahead, into the field of action, or out of the field of action of the muscle that was
Kommerell, G. (Guntram) +1 more
core +5 more sources